- Home
- VVPR vs CLNN Comparison
VVPR vs CLNN Comparison
Compare VVPR & CLNN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- VVPR
- CLNN
- Stock Information
- Founded
- VVPR 2014
- CLNN 2012
- Country
- VVPR United Kingdom
- CLNN United States
- Employees
- VVPR N/A
- CLNN N/A
- Industry
- VVPR Power Generation
- CLNN Biotechnology: Pharmaceutical Preparations
- Sector
- VVPR Utilities
- CLNN Health Care
- Exchange
- VVPR Nasdaq
- CLNN Nasdaq
- Market Cap
- VVPR 64.0M
- CLNN 60.3M
- IPO Year
- VVPR 2016
- CLNN N/A
- Fundamental
- Price
- VVPR $5.08
- CLNN $9.49
- Analyst Decision
- VVPR
- CLNN Strong Buy
- Analyst Count
- VVPR 0
- CLNN 6
- Target Price
- VVPR N/A
- CLNN $32.67
- AVG Volume (30 Days)
- VVPR 610.9K
- CLNN 149.6K
- Earning Date
- VVPR 01-01-0001
- CLNN 11-12-2025
- Dividend Yield
- VVPR N/A
- CLNN N/A
- EPS Growth
- VVPR N/A
- CLNN N/A
- EPS
- VVPR N/A
- CLNN N/A
- Revenue
- VVPR $79,000.00
- CLNN $286,000.00
- Revenue This Year
- VVPR N/A
- CLNN N/A
- Revenue Next Year
- VVPR N/A
- CLNN $1,363.77
- P/E Ratio
- VVPR N/A
- CLNN N/A
- Revenue Growth
- VVPR N/A
- CLNN N/A
- 52 Week Low
- VVPR $0.62
- CLNN $2.28
- 52 Week High
- VVPR $8.88
- CLNN $11.06
- Technical
- Relative Strength Index (RSI)
- VVPR 50.47
- CLNN 68.46
- Support Level
- VVPR $4.94
- CLNN $8.54
- Resistance Level
- VVPR $5.85
- CLNN $11.00
- Average True Range (ATR)
- VVPR 0.40
- CLNN 0.91
- MACD
- VVPR 0.04
- CLNN 0.29
- Stochastic Oscillator
- VVPR 48.53
- CLNN 71.36
About VVPR VivoPower International PLC
Vivopower International PLC is a solar power company. It provides energy infrastructure generation, and distribution solutions and is also engaged in the development, construction, and sale of photovoltaic(PV) solar projects. Its operating segments include Solar Development, Critical Power Services, Sustainable Energy Solutions, Electric Vehicles, and Corporate Office. The majority of the firm's revenue is generated from the Electric Vehicles segment. Geographically its key revenue derives from the Netherlands.
About CLNN Clene Inc.
Clene Inc is a clinical-stage pharmaceutical company pioneering the discovery, development, and commercialization of novel clean-surfaced nanotechnology (CSN) therapeutics. It is focused on the development of therapeutics for neurodegenerative diseases. It developed an electro-crystal-chemistry drug development platform that enables the production of concentrated, stable, clean-surfaced nanocrystal suspensions. It operates in one segment the development and commercialization of dietary supplements (Supplements). Products includes CNM-Au8, CNM-ZnA, CNM-AgZn17, rMetx, KHC46.